275 related articles for article (PubMed ID: 33650687)
1. Salivary levels of last generation specific pro-resolving lipid mediators (SPMs) (protectin and maresin) in patients with cardiovascular and periodontal disease: A case-control study.
Önal MA; Fentoğlu Ö; Aksoy F; Calapoğlu M; Varol E; Orhan H
J Periodontal Res; 2021 Jun; 56(3):606-615. PubMed ID: 33650687
[TBL] [Abstract][Full Text] [Related]
2. Periodontal and cardiovascular therapies modify specialized pro-resolving lipid mediator (sPRLM) (LPXA4, PD1, RvE1, RvD1, and MaR1)-mediated pathway: the first pilot clinical study.
Güvenç KK; Fentoğlu Ö; Calapoğlu M; Aksoy F; Orhan H
Clin Oral Investig; 2023 Sep; 27(9):5549-5558. PubMed ID: 37535198
[TBL] [Abstract][Full Text] [Related]
3. Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health/disease status.
Tobón-Arroyave SI; Isaza-Guzmán DM; Gómez-Ortega J; Flórez-Alzate AA
J Clin Periodontol; 2019 Oct; 46(10):978-990. PubMed ID: 31339183
[TBL] [Abstract][Full Text] [Related]
4. Increase in serum and salivary neutrophil gelatinase-associated lipocalin levels with increased periodontal inflammation.
Tan A; Gürbüz N; Özbalci Fİ; Koşkan Ö; Yetkin Ay Z
J Appl Oral Sci; 2020; 28():e20200276. PubMed ID: 32997091
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation.
Özcan E; Saygun NI; Serdar MA; Kurt N
Clin Oral Investig; 2015 May; 19(4):921-8. PubMed ID: 25164155
[TBL] [Abstract][Full Text] [Related]
6. Statherin and alpha-amylase levels in saliva from patients with gingivitis and periodontitis.
Parlak HM; Buber E; Gur AT; Karabulut E; Akalin FA
Arch Oral Biol; 2023 Jan; 145():105574. PubMed ID: 36395562
[TBL] [Abstract][Full Text] [Related]
7. Salivary infectious agents and periodontal disease status.
Saygun I; Nizam N; Keskiner I; Bal V; Kubar A; Açıkel C; Serdar M; Slots J
J Periodontal Res; 2011 Apr; 46(2):235-9. PubMed ID: 21261620
[TBL] [Abstract][Full Text] [Related]
8. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease.
Inönü E; Kayis SA; Eskan MA; Hakki SS
J Periodontal Res; 2020 Aug; 55(4):511-518. PubMed ID: 32153040
[TBL] [Abstract][Full Text] [Related]
9. Developments of specialized pro-resolving mediators in periodontitis.
Liu YC
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Feb; 39(1):94-98. PubMed ID: 33723943
[TBL] [Abstract][Full Text] [Related]
10. Gingival crevicular fluid and salivary HIF-1α, VEGF, and TNF-α levels in periodontal health and disease.
Afacan B; Öztürk VÖ; Paşalı Ç; Bozkurt E; Köse T; Emingil G
J Periodontol; 2019 Jul; 90(7):788-797. PubMed ID: 30536725
[TBL] [Abstract][Full Text] [Related]
11. Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
Noack B; Kipping T; Tervahartiala T; Sorsa T; Hoffmann T; Lorenz K
J Periodontal Res; 2017 Oct; 52(5):824-831. PubMed ID: 28345244
[TBL] [Abstract][Full Text] [Related]
12. Salivary levels of inflammatory cytokines and their association to periodontal disease in systemic lupus erythematosus patients. A case-control study.
Marques CP; Victor EC; Franco MM; Fernandes JM; Maor Y; de Andrade MS; Rodrigues VP; Benatti BB
Cytokine; 2016 Sep; 85():165-70. PubMed ID: 27371775
[TBL] [Abstract][Full Text] [Related]
13. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress.
Önder C; Kurgan Ş; Altıngöz SM; Bağış N; Uyanık M; Serdar MA; Kantarcı A; Günhan M
Clin Oral Investig; 2017 Jul; 21(6):1961-1969. PubMed ID: 27807715
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of salivary leucine-rich alpha-2 glycoprotein (LRG) and C-reactive protein (CRP) in humans with periodontal health or periodontal disease.
Özer E; Yilmaz HE; Narin F; Sağlam M
J Periodontal Res; 2024 Apr; 59(2):387-394. PubMed ID: 38126217
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of salivary oxidative stress in patients with familial Mediterranean fever and chronic periodontitis.
Dinç G; Fentoğlu Ö; Doğru A; İlhan İ; Kırzıoğlu FY; Orhan H
J Periodontol; 2018 Sep; 89(9):1112-1120. PubMed ID: 29761911
[TBL] [Abstract][Full Text] [Related]
16. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
Recchiuti A; Serhan CN
Front Immunol; 2012; 3():298. PubMed ID: 23093949
[TBL] [Abstract][Full Text] [Related]
17. Salivary histone deacetylase in periodontal disease: A cross-sectional pilot study.
Liaw A; Liu C; Bartold M; Ivanovski S; Han P
J Periodontal Res; 2023 Apr; 58(2):433-443. PubMed ID: 36717759
[TBL] [Abstract][Full Text] [Related]
18. Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation.
Hasturk H; Schulte F; Martins M; Sherzai H; Floros C; Cugini M; Chiu CJ; Hardt M; Van Dyke T
Front Immunol; 2021; 12():704163. PubMed ID: 34589083
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin levels of unstimulated saliva from naval recruits with and without chronic inflammatory periodontal disease.
Lamberts BL; Pederson ED; Bial JJ; Tombasco PK
J Clin Periodontol; 1989 Jul; 16(6):342-6. PubMed ID: 2668347
[TBL] [Abstract][Full Text] [Related]
20. Arginine-nitric oxide-polyamine metabolism in periodontal disease.
Ozer L; Elgun S; Ozdemir B; Pervane B; Ozmeric N
J Periodontol; 2011 Feb; 82(2):320-8. PubMed ID: 20831369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
